RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ra Medical Systems Stock

Ra Medical Systems P/S 2024

Ra Medical Systems P/S

0.05

Ticker

RMED

ISIN

US74933X2036

WKN

A2QJCG

As of Nov 16, 2024, Ra Medical Systems's P/S ratio stood at 0.05, a -91.23% change from the 0.57 P/S ratio recorded in the previous year.

The Ra Medical Systems P/S history

Ra Medical Systems Aktienanalyse

What does Ra Medical Systems do?

Ra Medical Systems Inc. is a California-based company specializing in the development and sale of medical devices for the treatment of vascular diseases. The company was founded in 2002 and is headquartered in Carlsbad. The company was founded by Dr. Dean Irwin and Dr. Melissa Burstein, both experts in laser therapy. The company initially focused on developing laser systems for the treatment of skin diseases. In 2016, the company changed its business strategy and shifted its focus to the development of medical devices for the treatment of vascular diseases. Since then, the company has become a leading provider of devices for the treatment of peripheral artery occlusive disease (PAOD) and other vascular diseases. The business model of Ra Medical Systems Inc. is based on selling high-tech medical devices and their corresponding accessories. The company sells its products directly to medical facilities and healthcare providers in the US and some international markets. The company also provides training, technical support, and service to ensure the safe and effective use of its products. Ra Medical Systems Inc. offers two main products: the DABRA™ System and the Pharos™ System. Both systems use pulsed laser therapy for the treatment of vascular diseases. The DABRA™ System is a laser system specifically designed for the treatment of peripheral artery occlusive disease (PAOD). It is the only FDA-approved system that offers atherectomy laser therapy. The system enables fast and safe treatment of blocked arteries and is less invasive than traditional surgical procedures. The DABRA™ System also has the potential to reduce the need for long-term medication and repeated procedures, which can lower treatment costs. The Pharos™ System is a laser system specifically designed for the treatment of skin diseases such as psoriasis, vitiligo, and atopic dermatitis. The system uses a high-energy dose to selectively destroy abnormal functioning tissue without affecting surrounding tissue. The Pharos™ System has the potential to improve the quality of life for patients with skin diseases and expand therapeutic options for this patient group. Ra Medical Systems Inc. also offers a complete accessory catalog for its products, including catheters and accessories for the DABRA™ System and handpieces and cooling devices for the Pharos™ System. In conclusion, Ra Medical Systems Inc. is a leading provider of medical devices for the treatment of vascular diseases and skin diseases. The company specializes in the development of high-tech laser systems that provide safe and effective procedures for patients and doctors. The DABRA™ System is a revolutionary laser system for the treatment of PAOD that has the potential to reduce the need for invasive surgical procedures and long-term medication. The Pharos™ System expands therapeutic options for patients with skin diseases and has the potential to improve the quality of life for this patient group. Ra Medical Systems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Ra Medical Systems's P/S Ratio

Ra Medical Systems's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Ra Medical Systems's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Ra Medical Systems's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Ra Medical Systems’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Ra Medical Systems stock

What is the price-to-earnings ratio of Ra Medical Systems?

The price-earnings ratio of Ra Medical Systems is currently 0.05.

How has the price-earnings ratio of Ra Medical Systems changed compared to last year?

The price-to-earnings ratio of Ra Medical Systems has increased by -91.23% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Ra Medical Systems high compared to other companies?

Yes, the price-to-earnings ratio of Ra Medical Systems is high compared to other companies.

How does an increase in the price-earnings ratio of Ra Medical Systems affect the company?

An increase in the price-earnings ratio of Ra Medical Systems would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Ra Medical Systems affect the company?

A decrease in the price-earnings ratio of Ra Medical Systems would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Ra Medical Systems?

Some factors that influence the price-earnings ratio of Ra Medical Systems are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Ra Medical Systems pay?

Over the past 12 months, Ra Medical Systems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ra Medical Systems is expected to pay a dividend of 0 USD.

What is the dividend yield of Ra Medical Systems?

The current dividend yield of Ra Medical Systems is .

When does Ra Medical Systems pay dividends?

Ra Medical Systems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ra Medical Systems?

Ra Medical Systems paid dividends every year for the past 0 years.

What is the dividend of Ra Medical Systems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ra Medical Systems located?

Ra Medical Systems is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ra Medical Systems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ra Medical Systems from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did Ra Medical Systems pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of Ra Medical Systems in the year 2023?

In the year 2023, Ra Medical Systems distributed 0 USD as dividends.

In which currency does Ra Medical Systems pay out the dividend?

The dividends of Ra Medical Systems are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ra Medical Systems

Our stock analysis for Ra Medical Systems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ra Medical Systems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.